Evidence map›Paper›PMID 36399043›Full record

ArticleJournal of hepato-biliary-pancreatic sciences2023

Sequential histologic evolution of gallbladder inflammation in acute cholecystitis over the first 10 days after onset of symptoms.

Roheena Z Panni, Deyali Chatterjee, Usman Y Panni, Keenan J Robbins, Jingxia Liu, Steven M Strasberg

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of hepato-biliary-pancreatic sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05712733 unknown statusnot on this map

Cholecystitis From a Microbiological and Histopathological Perspective

Typeobservational_patient_registrySponsorOrgankirurgisk afdeling, sygehus lillebælt, KoldingRan2023 to 2025Enrolled60ConditionsCalculous Cholecystitis, Antibiotic Resistant Infection, Gallbladder InflammationArmsMicrobiological and histopathological investigation of bile and gallbladder wall specimens.
NCT06048575 completednot on this mapstarted 2025, after this paper: background citation

Characteristics of the Attention Provided to Patients With Cholecystitis in Villavicencio Hospitals, Colombia: A Retrospective Cross-sectional Trial.

TypeobservationalSponsorHospital Departamental de VillavicencioRan2025 to 2025Enrolled609ConditionsBiliary Tract DiseasesArmsCholecystectomy
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Roheena Z PanniSection of Hepato-biliary Surgery, Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, Missouri, USA.
Deyali ChatterjeeDepartment of Pathology and Immunology, Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, Missouri, USA.
Usman Y PanniSection of Hepato-biliary Surgery, Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, Missouri, USA.
Keenan J RobbinsSection of Hepato-biliary Surgery, Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, Missouri, USA.
Jingxia LiuDivision of Public Health Sciences, Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, Missouri, USA.
Steven M StrasbergSection of Hepato-biliary Surgery, Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-0777-2698
Barnes-Jewish Hospital · US

Funding

SURGICAL ONCOLOGY TRAINING GRANTT32CA009621 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN, William E. Gillanders · 1988 to 2026
$12.9M
Washington University SPORE in Pancreatic CancerP50CA272213 · NCI · WASHINGTON UNIVERSITY · PI David G DeNardo, WILLIAM G HAWKINS · 2023 to 2026
$10.7M
UW Surgical Oncology Research Training Program (UW-SORT)T32CA090217 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Muhammed Murtaza, Heather B Neuman · 2001 to 2026
$8.3M
NCI NIH HHS P50 CA272213NCI NIH HHS T32 CA009621NCI NIH HHS T32 CA090217
6 · The paper itself

Abstract

backgroundThe timing of cholecystectomy during acute cholecystitis (AC) is controversial, especially whether it is advisable to perform in patients with duration of symptoms between 3 and 10 days. The purpose of this study is to define clearly the sequential evolution of histological changes following symptoms onset to guide recommendations regarding timing of cholecystectomy.

methodsWe identified patients with AC (2005-2018) who had cholecystectomy within 10 days of symptom onset of a first attack of AC. Histologic features of gallbladder injury including cellular and exudative inflammatory response to injury were determined on blinded pathologic slides.

resultsOne hundred and forty-nine patients were divided into three groups; early-who underwent cholecystectomy 1-3 days after symptom-onset, intermediate-4-6 days, and late-7-10 days. Key features of injury were necrosis and hemorrhage. A subgroup of patients in the early phase developed severe necrosis and hemorrhage of an extent associated with difficult cholecystectomy. Large spikes in extent of necrosis and hemorrhage occurred at 7-10 days. Major inflammatory responses to injury were eosinophilic and lymphocytic infiltration and early fibrosis.

conclusionsSevere necrosis may develop rapidly and be present in the early period after symptom onset of AC. Cholecystectomy may be reasonable in some patients but by day 7-10, severe necrosis and hemorrhage may be expected to be present in most patients.

Indexed as

Cholecystectomy, LaparoscopicCholecystitisCholecystitis, AcuteCholecystectomyGallbladderHumansNecrosisRetrospective Studiesacute cholecystitisgallbladder hemorrhagegallbladder myofibroblastsgallbladder necrosis

Identifiers

PMID36399043
PMCPMC12228971
OpenAlexW4309363363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.